Spotlight on Psychiatry
Your Words Matter – Language Showing Compassion and Care for Women, Infants, Families, and Communities Impacted by Substance Use Disorder
StartActivity Details
0.75 ANCC Contact hour(s)
0.75 ACPE Contact hour(s) (0.075 CEUs)
0.75 ADA Continuing education credit(s)
Expires: October 17, 2022
Provided By
Target Audience
This activity is intended for physicians, physician assistants, pharmacists, registered nurses, nurse practitioners/other APRNs, and dentists engaged in the care of patients with substance use disorders.
Learning Objectives
After completing this activity, the participant should be better able to:
- Explain the effects of stigmatizing language on patients with addiction.
- Describe the effects of stigma on pregnant women and mothers.
- Compare common terminology and assess which terms should be used or avoided and why.
- Integrate person-first, non-stigmatizing language into everyday practice.
- Identify terms to use and terms to avoid when speaking to patients about addiction.
Activity Description
This CME/CE activity highlights your role in helping destigmatize addiction and substance use disorder and reduce negative bias among pregnant women and mothers. The activity has background information and tips for providers on language to use or avoid.
Course Director
Michelle Corbin, MBA
NIDAMED Coordinator
National Institute on Drug Abuse
Rockville, MD
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The PIM planners and others have nothing to disclose.
The following planners and others have nothing to disclose: Hendree Jones, Michelle Corbin from the National Institute on Drug Abuse, Melinda Campopiano, Erika Capinguian, Susan Hayashi, and Laura Nolan from JBS International, Inc.
Joint Accreditation Statement
In support
of improving patient care, this activity has been planned and implemented by
the Postgraduate Institute for Medicine and the National Institute on Drug
Abuse. Postgraduate Institute for Medicine is jointly accredited by the
Accreditation Council for Continuing Medical Education (ACCME), the
Accreditation Council for Pharmacy Education (ACPE), and the American Nurses
Credentialing Center (ANCC), to provide continuing education for the
healthcare team.
Physician Continuing Medical Education
Postgraduate Institute for Medicine designates this enduring material for a
maximum of 0.75 AMA PRA Category 1
Credit(s)™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education
activity is 0.75 contact hour(s).
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education
activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council
for Pharmacy Education.
(Universal Activity Number – JA4008162-9999-21-2679-H01-P)
Type of Activity: Knowledge
Continuing Dental Education
Postgraduate Institute for Medicine is an ADA CERP Recognized Provider. ADA
CERP is a service of the American Dental Association to assist dental
professionals in identifying quality providers of continuing dental
education. ADA CERP does not approve or endorse individual courses or
instructors, nor does it imply acceptance of the credit hours by boards of
dentistry. Concerns or complaints about a CE provider may be directed to the
provider or to the Commission for Continuing Education Provider Recognition
at ADA.org/CERP.
Postgraduate Institute for Medicine designates this activity for 0.75 continuing education credit(s).
Statement of Commercial Support
There is no commercial funding for this activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Hardware/Software Requirements
Content is accessible regardless of internet browser. However, the Google Chrome browser often performs best.
Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
Contact Information for Questions About the Activity
If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com.
Activity Details
0.75 ANCC Contact hour(s)
0.75 ACPE Contact hour(s) (0.075 CEUs)
0.75 ADA Continuing education credit(s)
Expires: October 17, 2022
Provided By
Target Audience
This activity is intended for physicians, physician assistants, pharmacists, registered nurses, nurse practitioners/other APRNs, and dentists engaged in the care of patients with substance use disorders.
Learning Objectives
After completing this activity, the participant should be better able to:
- Explain the effects of stigmatizing language on patients with addiction.
- Describe the effects of stigma on pregnant women and mothers.
- Compare common terminology and assess which terms should be used or avoided and why.
- Integrate person-first, non-stigmatizing language into everyday practice.
- Identify terms to use and terms to avoid when speaking to patients about addiction.
Activity Description
This CME/CE activity highlights your role in helping destigmatize addiction and substance use disorder and reduce negative bias among pregnant women and mothers. The activity has background information and tips for providers on language to use or avoid.
Course Director
Michelle Corbin, MBA
NIDAMED Coordinator
National Institute on Drug Abuse
Rockville, MD
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The PIM planners and others have nothing to disclose.
The following planners and others have nothing to disclose: Hendree Jones, Michelle Corbin from the National Institute on Drug Abuse, Melinda Campopiano, Erika Capinguian, Susan Hayashi, and Laura Nolan from JBS International, Inc.
Joint Accreditation Statement
In support
of improving patient care, this activity has been planned and implemented by
the Postgraduate Institute for Medicine and the National Institute on Drug
Abuse. Postgraduate Institute for Medicine is jointly accredited by the
Accreditation Council for Continuing Medical Education (ACCME), the
Accreditation Council for Pharmacy Education (ACPE), and the American Nurses
Credentialing Center (ANCC), to provide continuing education for the
healthcare team.
Physician Continuing Medical Education
Postgraduate Institute for Medicine designates this enduring material for a
maximum of 0.75 AMA PRA Category 1
Credit(s)™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education
activity is 0.75 contact hour(s).
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education
activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council
for Pharmacy Education.
(Universal Activity Number – JA4008162-9999-21-2679-H01-P)
Type of Activity: Knowledge
Continuing Dental Education
Postgraduate Institute for Medicine is an ADA CERP Recognized Provider. ADA
CERP is a service of the American Dental Association to assist dental
professionals in identifying quality providers of continuing dental
education. ADA CERP does not approve or endorse individual courses or
instructors, nor does it imply acceptance of the credit hours by boards of
dentistry. Concerns or complaints about a CE provider may be directed to the
provider or to the Commission for Continuing Education Provider Recognition
at ADA.org/CERP.
Postgraduate Institute for Medicine designates this activity for 0.75 continuing education credit(s).
Statement of Commercial Support
There is no commercial funding for this activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Hardware/Software Requirements
Content is accessible regardless of internet browser. However, the Google Chrome browser often performs best.
Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
Contact Information for Questions About the Activity
If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com.
Psychiatry Presentations
Words Matter – Terms to Use and Avoid When Talking About Addiction
StartActivity Details
0.75 ANCC Contact hour(s)
0.75 ACPE Contact hour(s) (0.075 CEUs)
0.75 ADA Continuing education credit(s)
Expires: October 17, 2022
Provided By
Target Audience
This activity is intended for physicians, physician assistants, pharmacists, registered nurses, nurse practitioners/other APRNs, and dentists engaged in the care of patients with substance use disorders.
Learning Objectives
After completing this activity, the participant should be better able to:
- Explain the effects of stigmatizing language on patients with addiction.
- Compare common terminology and assess which terms should be used or avoided and why.
- Integrate person-first, non-stigmatizing language into everyday practice.
- Identify terms to use and terms to avoid when speaking to patients about addiction.
Activity Description
This CME/CE activity informs clinicians on how they can show leadership in how language can destigmatize the disease of addiction. It is focused on using person-first language, as well as terms to avoid to reduce stigma and negative bias when discussing addiction.
Course Director
Michelle Corbin, MBA
NIDAMED Coordinator
National Institute on Drug Abuse
Rockville, MD
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The PIM planners and others have nothing to disclose.
The following planners and others have nothing to disclose: Michelle Corbin from the National Institute on Drug Abuse, Melinda Campopiano, Erika Capinguian, Susan Hayashi, and Laura Nolan from JBS International, Inc.
Joint Accreditation Statement
In support
of improving patient care, this activity has been planned and implemented by
the Postgraduate Institute for Medicine and the National Institute on Drug
Abuse. Postgraduate Institute for Medicine is jointly accredited by the
Accreditation Council for Continuing Medical Education (ACCME), the
Accreditation Council for Pharmacy Education (ACPE), and the American Nurses
Credentialing Center (ANCC), to provide continuing education for the
healthcare team.
Physician Continuing Medical Education
Postgraduate Institute for Medicine designates this enduring material for a
maximum of 0.75 AMA PRA Category 1
Credit(s)™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education
activity is 0.75 contact hour(s).
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education
activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council
for Pharmacy Education.
(Universal Activity Number – JA4008162-9999-21-2678-H01-P)
Type of Activity: Knowledge
Continuing Dental Education
Postgraduate Institute for Medicine is an ADA CERP Recognized Provider. ADA
CERP is a service of the American Dental Association to assist dental
professionals in identifying quality providers of continuing dental
education. ADA CERP does not approve or endorse individual courses or
instructors, nor does it imply acceptance of the credit hours by boards of
dentistry. Concerns or complaints about a CE provider may be directed to the
provider or to the Commission for Continuing Education Provider Recognition
at ADA.org/CERP.
Postgraduate Institute for Medicine designates this activity for 0.75 continuing education credit(s).
Statement of Commercial Support
There is no commercial funding for this activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Hardware/Software Requirements
Content is accessible regardless of internet browser. However, the Google Chrome browser often performs best.
Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
Contact Information for Questions About the Activity
If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com.
Activity Details
0.75 ANCC Contact hour(s)
0.75 ACPE Contact hour(s) (0.075 CEUs)
0.75 ADA Continuing education credit(s)
Expires: October 17, 2022
Provided By
Target Audience
This activity is intended for physicians, physician assistants, pharmacists, registered nurses, nurse practitioners/other APRNs, and dentists engaged in the care of patients with substance use disorders.
Learning Objectives
After completing this activity, the participant should be better able to:
- Explain the effects of stigmatizing language on patients with addiction.
- Compare common terminology and assess which terms should be used or avoided and why.
- Integrate person-first, non-stigmatizing language into everyday practice.
- Identify terms to use and terms to avoid when speaking to patients about addiction.
Activity Description
This CME/CE activity informs clinicians on how they can show leadership in how language can destigmatize the disease of addiction. It is focused on using person-first language, as well as terms to avoid to reduce stigma and negative bias when discussing addiction.
Course Director
Michelle Corbin, MBA
NIDAMED Coordinator
National Institute on Drug Abuse
Rockville, MD
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The PIM planners and others have nothing to disclose.
The following planners and others have nothing to disclose: Michelle Corbin from the National Institute on Drug Abuse, Melinda Campopiano, Erika Capinguian, Susan Hayashi, and Laura Nolan from JBS International, Inc.
Joint Accreditation Statement
In support
of improving patient care, this activity has been planned and implemented by
the Postgraduate Institute for Medicine and the National Institute on Drug
Abuse. Postgraduate Institute for Medicine is jointly accredited by the
Accreditation Council for Continuing Medical Education (ACCME), the
Accreditation Council for Pharmacy Education (ACPE), and the American Nurses
Credentialing Center (ANCC), to provide continuing education for the
healthcare team.
Physician Continuing Medical Education
Postgraduate Institute for Medicine designates this enduring material for a
maximum of 0.75 AMA PRA Category 1
Credit(s)™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education
activity is 0.75 contact hour(s).
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education
activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council
for Pharmacy Education.
(Universal Activity Number – JA4008162-9999-21-2678-H01-P)
Type of Activity: Knowledge
Continuing Dental Education
Postgraduate Institute for Medicine is an ADA CERP Recognized Provider. ADA
CERP is a service of the American Dental Association to assist dental
professionals in identifying quality providers of continuing dental
education. ADA CERP does not approve or endorse individual courses or
instructors, nor does it imply acceptance of the credit hours by boards of
dentistry. Concerns or complaints about a CE provider may be directed to the
provider or to the Commission for Continuing Education Provider Recognition
at ADA.org/CERP.
Postgraduate Institute for Medicine designates this activity for 0.75 continuing education credit(s).
Statement of Commercial Support
There is no commercial funding for this activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Hardware/Software Requirements
Content is accessible regardless of internet browser. However, the Google Chrome browser often performs best.
Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
Contact Information for Questions About the Activity
If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com.
Your Words Matter – Language Showing Compassion and Care for Women, Infants, Families, and Communities Impacted by Substance Use Disorder
StartActivity Details
0.75 ANCC Contact hour(s)
0.75 ACPE Contact hour(s) (0.075 CEUs)
0.75 ADA Continuing education credit(s)
Expires: October 17, 2022
Provided By
Target Audience
This activity is intended for physicians, physician assistants, pharmacists, registered nurses, nurse practitioners/other APRNs, and dentists engaged in the care of patients with substance use disorders.
Learning Objectives
After completing this activity, the participant should be better able to:
- Explain the effects of stigmatizing language on patients with addiction.
- Describe the effects of stigma on pregnant women and mothers.
- Compare common terminology and assess which terms should be used or avoided and why.
- Integrate person-first, non-stigmatizing language into everyday practice.
- Identify terms to use and terms to avoid when speaking to patients about addiction.
Activity Description
This CME/CE activity highlights your role in helping destigmatize addiction and substance use disorder and reduce negative bias among pregnant women and mothers. The activity has background information and tips for providers on language to use or avoid.
Course Director
Michelle Corbin, MBA
NIDAMED Coordinator
National Institute on Drug Abuse
Rockville, MD
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The PIM planners and others have nothing to disclose.
The following planners and others have nothing to disclose: Hendree Jones, Michelle Corbin from the National Institute on Drug Abuse, Melinda Campopiano, Erika Capinguian, Susan Hayashi, and Laura Nolan from JBS International, Inc.
Joint Accreditation Statement
In support
of improving patient care, this activity has been planned and implemented by
the Postgraduate Institute for Medicine and the National Institute on Drug
Abuse. Postgraduate Institute for Medicine is jointly accredited by the
Accreditation Council for Continuing Medical Education (ACCME), the
Accreditation Council for Pharmacy Education (ACPE), and the American Nurses
Credentialing Center (ANCC), to provide continuing education for the
healthcare team.
Physician Continuing Medical Education
Postgraduate Institute for Medicine designates this enduring material for a
maximum of 0.75 AMA PRA Category 1
Credit(s)™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education
activity is 0.75 contact hour(s).
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education
activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council
for Pharmacy Education.
(Universal Activity Number – JA4008162-9999-21-2679-H01-P)
Type of Activity: Knowledge
Continuing Dental Education
Postgraduate Institute for Medicine is an ADA CERP Recognized Provider. ADA
CERP is a service of the American Dental Association to assist dental
professionals in identifying quality providers of continuing dental
education. ADA CERP does not approve or endorse individual courses or
instructors, nor does it imply acceptance of the credit hours by boards of
dentistry. Concerns or complaints about a CE provider may be directed to the
provider or to the Commission for Continuing Education Provider Recognition
at ADA.org/CERP.
Postgraduate Institute for Medicine designates this activity for 0.75 continuing education credit(s).
Statement of Commercial Support
There is no commercial funding for this activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Hardware/Software Requirements
Content is accessible regardless of internet browser. However, the Google Chrome browser often performs best.
Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
Contact Information for Questions About the Activity
If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com.
Activity Details
0.75 ANCC Contact hour(s)
0.75 ACPE Contact hour(s) (0.075 CEUs)
0.75 ADA Continuing education credit(s)
Expires: October 17, 2022
Provided By
Target Audience
This activity is intended for physicians, physician assistants, pharmacists, registered nurses, nurse practitioners/other APRNs, and dentists engaged in the care of patients with substance use disorders.
Learning Objectives
After completing this activity, the participant should be better able to:
- Explain the effects of stigmatizing language on patients with addiction.
- Describe the effects of stigma on pregnant women and mothers.
- Compare common terminology and assess which terms should be used or avoided and why.
- Integrate person-first, non-stigmatizing language into everyday practice.
- Identify terms to use and terms to avoid when speaking to patients about addiction.
Activity Description
This CME/CE activity highlights your role in helping destigmatize addiction and substance use disorder and reduce negative bias among pregnant women and mothers. The activity has background information and tips for providers on language to use or avoid.
Course Director
Michelle Corbin, MBA
NIDAMED Coordinator
National Institute on Drug Abuse
Rockville, MD
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The PIM planners and others have nothing to disclose.
The following planners and others have nothing to disclose: Hendree Jones, Michelle Corbin from the National Institute on Drug Abuse, Melinda Campopiano, Erika Capinguian, Susan Hayashi, and Laura Nolan from JBS International, Inc.
Joint Accreditation Statement
In support
of improving patient care, this activity has been planned and implemented by
the Postgraduate Institute for Medicine and the National Institute on Drug
Abuse. Postgraduate Institute for Medicine is jointly accredited by the
Accreditation Council for Continuing Medical Education (ACCME), the
Accreditation Council for Pharmacy Education (ACPE), and the American Nurses
Credentialing Center (ANCC), to provide continuing education for the
healthcare team.
Physician Continuing Medical Education
Postgraduate Institute for Medicine designates this enduring material for a
maximum of 0.75 AMA PRA Category 1
Credit(s)™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education
activity is 0.75 contact hour(s).
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education
activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council
for Pharmacy Education.
(Universal Activity Number – JA4008162-9999-21-2679-H01-P)
Type of Activity: Knowledge
Continuing Dental Education
Postgraduate Institute for Medicine is an ADA CERP Recognized Provider. ADA
CERP is a service of the American Dental Association to assist dental
professionals in identifying quality providers of continuing dental
education. ADA CERP does not approve or endorse individual courses or
instructors, nor does it imply acceptance of the credit hours by boards of
dentistry. Concerns or complaints about a CE provider may be directed to the
provider or to the Commission for Continuing Education Provider Recognition
at ADA.org/CERP.
Postgraduate Institute for Medicine designates this activity for 0.75 continuing education credit(s).
Statement of Commercial Support
There is no commercial funding for this activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Hardware/Software Requirements
Content is accessible regardless of internet browser. However, the Google Chrome browser often performs best.
Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
Contact Information for Questions About the Activity
If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com.